Last Updated: May 11, 2026

List of Excipients in API milnacipran hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing milnacipran hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc SAVELLA milnacipran hydrochloride 0456-1512 CARBOXYMETHYLCELLULOSE CALCIUM
Allergan Inc SAVELLA milnacipran hydrochloride 0456-1512 DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Allergan Inc SAVELLA milnacipran hydrochloride 0456-1512 FD&C BLUE NO. 2
Allergan Inc SAVELLA milnacipran hydrochloride 0456-1512 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing milnacipran hydrochloride

Company Ingredient NDC Excipient
Camber Pharmaceuticals Inc milnacipran hydrochloride 31722-846 CARBOXYMETHYLCELLULOSE CALCIUM
Camber Pharmaceuticals Inc milnacipran hydrochloride 31722-846 FD&C BLUE NO. 2 ALUMINUM LAKE
Camber Pharmaceuticals Inc milnacipran hydrochloride 31722-846 MAGNESIUM STEARATE
Camber Pharmaceuticals Inc milnacipran hydrochloride 31722-846 METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for milnacipran hydrochloride

Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSPOVIDONE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 112

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links